Globally, in 2017 35 million people were living with HIV (PLHIV) and 257 million had chronic
HBV infection (HBsAg positive). The extent of HIV‐HBsAg co‐infection is unknown. We …

Early diagnosis of tuberculosis (TB), followed by effective treatment, is the cornerstone of
global TB control efforts. An estimated 3 million cases of TB remain undetected each year …

Millions of children are exposed to tuberculosis (TB) each year, many of which become
infected with Mycobacterium tuberculosis. Most children can immunologically contain or …

AIM: To assess the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV)
infection and association with drug induced liver injury (DILI) in patients undergoing anti …

Objective: Viral hepatitis, particularly hepatitis B virus and hepatitis C virus, is the leading
cause of global liver-related morbidity and mortality. Concomitant infections of hepatitis B …

Background This study was conducted to estimate the prevalence, determinants of hepatitis
B, hepatitis C and the survival of tuberculosis patients until drug-induced hepatitis. Methods …

Literature surrounding the burden of and factors associated with hepatitis B virus (HBV) and
hepatitis C virus (HCV) infection in persons with tuberculosis (TB) disease remains limited …

BACKGROUND: Due to environmental and social conditions inherent to incarceration,
tuberculosis (TB) and hepatitis B virus (HBV) are major diseases among prison inmates …

Background The burden of parallel and overlapping infections of Sexually Transmitted
Infections (STIs), particularly HIV, syphilis, hepatitis B (HBV), and hepatitis C virus (HCV) are …

Background Hepatitis B virus (HBV) and hepatitis C virus (HCV) are hepatotropic viruses
whose primary replication occurs in the liver. Despite the significant clinical importance of …